DIANE MAROLDA: Open Payments
NPI 1841278892 · HAMILTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 56 payments from 14 companies in 2025. Trend: 2023 $643 · 2024 $1,093 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 10 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $150 |
| Amgen Inc. | 16 | $142 |
| Actelion Pharmaceuticals US, Inc. | 8 | $132 |
| Novo Nordisk Inc | 3 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Kestra Medical Technology Services, Inc. | 1 | $30 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: WATCHMAN FLX, REPATHA, UPTRAVI, Adempas, Kerendia, Wegovy, LEQVIO, OPSUMIT.
Industry payments across NJ — which companies pay providers there.
